What is the “Sequence Listing XML” and why is it important?
The “Sequence Listing XML” is a critical component of patent applications filed on or after July 1, 2022, that contain disclosures of nucleotide and/or amino acid sequences. It must comply with WIPO Standard ST.26 and include a sequence data part. As stated in MPEP 2413.01(g): “The sequence data part is the part of the ‘Sequence…
Read MoreWhat are the requirements for sequence identifiers in a “Sequence Listing XML”?
According to MPEP 2412.05(a), sequence identifiers in a “Sequence Listing XML” must adhere to specific requirements: Each disclosed nucleotide or amino acid sequence meeting the requirements of 37 CFR 1.831(b) must appear separately in the “Sequence Listing XML”. Each sequence must be assigned a separate sequence identifier. Sequence identifiers must begin with 1 and increase…
Read MoreWhat are the requirements for submitting a Sequence Listing in XML format?
What are the requirements for submitting a Sequence Listing in XML format? According to MPEP 2415.01, a Sequence Listing in XML format must be submitted when: An application discloses nucleotide and/or amino acid sequences that must be included in a “Sequence Listing” The application is filed on or after July 1, 2022 The MPEP states:…
Read MoreWhat format is required for submitting sequence listings in provisional applications filed on or after July 1, 2022?
For provisional applications filed on or after July 1, 2022, if an applicant chooses to submit nucleotide and/or amino acid sequence data, it must be in a specific format. The MPEP states: if submitted in a provisional application filed on or after July 1, 2022, any submission of nucleotide and/or amino acid sequence data must…
Read MoreWhat is a “Sequence Listing XML” and why must it be valid according to the DTD?
A “Sequence Listing XML” is a standardized format for presenting nucleotide and/or amino acid sequences in patent applications. It must be valid according to the Document Type Definition (DTD) as specified in MPEP § 2413.01(b) and 37 CFR 1.833(b)(1). The MPEP states: “The ‘Sequence Listing XML’ presented in accordance with paragraph (a) of this section…
Read MoreWhat are the requirements for content of a “Sequence Listing” part of the specification under WIPO ST.25?
The requirements for the content of a “Sequence Listing” part of the specification under WIPO ST.25 are outlined in 37 CFR 1.823. However, it’s important to note that these requirements are not applicable to all patent applications. As stated in the MPEP: “[Editor Note: This section is not applicable to applications filed on or after…
Read MoreWhat are the requirements for submitting a “Sequence Listing” in a patent application?
According to MPEP 2427, patent applications containing nucleotide and/or amino acid sequence disclosures must include a “Sequence Listing” as a separate part of the disclosure. This can be submitted in several ways: As an ASCII text file via the USPTO’s electronic filing system On read-only optical discs As a PDF file via EFS-Web or Patent…
Read MoreWhat are the requirements for representing nucleotide and amino acid sequences in a “Sequence Listing”?
According to MPEP 2423.01, the requirements for representing nucleotide and amino acid sequences in a “Sequence Listing” are as follows: The symbols for nucleotide and amino acid characters must be those set forth in Appendices A and C to Subpart G of Part 1 of the CFR. No other symbols shall be used in nucleotide…
Read MoreWhat are the length thresholds for nucleotide and amino acid sequences requiring a “Sequence Listing”?
According to MPEP 2422.01, the length thresholds for nucleotide and amino acid sequences requiring a “Sequence Listing” are: An unbranched sequence of four or more amino acids An unbranched sequence of ten or more nucleotides The MPEP states: “Nucleotide and/or amino acid sequences as used in 37 CFR 1.821 through 37 CFR 1.825 are interpreted…
Read MoreHow should sequence identifiers (SEQ ID NOs) be used in patent applications?
Sequence identifiers (SEQ ID NOs) are crucial in patent applications containing nucleotide and/or amino acid sequences. According to MPEP 2421.02: Each disclosed nucleotide and/or amino acid sequence must be assigned a unique SEQ ID NO. SEQ ID NOs must be used to identify sequences in the specification, claims, and drawings. The SEQ ID NO should…
Read More